Investigating Novel HIV Reservoirs in the Pulmonary Vasculature
- Institution
- TEXAS TECH UNIVERSITY HEALTH SCIS CENTER, TX
- Principal investigator
- Sharilyn Almodovar
- Funding
- $190K
- Duration
- 2024–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Infections with Human Immunodeficiency Virus (HIV) remain a major global public health concern. The HIV reservoirs are a leading reason for which HIV infection remains without a cure. HIV integrates its viral DNA into the host cell DNA. Cell activation leads to transcription of archived viral information, which can refuel viral replication even in the presence of antiretroviral therapy (ART). This may be problematic when cellular reservoirs of HIV involve cell types that are in continuous functional activation. Research conducted by others and us have shown that pvSMC are susceptible to HIV infection. In addition, people living with HIV (PLWH) are more prone to comorbidities that involve chronic vascular constriction. Our preliminary studies suggest that pulmonary arterial smooth muscle cells are susceptible to HIV infection, sustain the infection during ART-induced viral suppression, and are capable to release infectious viruses that can infect bystander T cells. Our preliminary findings have significant importance because identifying and eliminating HIV reservoirs such as pvSMC is critical to the success of global efforts to cure HIV. The fact that PLWH are more prone to pulmonary vasoconstrictive diseases implies that the persistent cell activation and vasoconstriction of pvSMC are likely to provide transcriptionally active HIV leading to reseeding of reservoirs. The pulmonary vasculature is heavily overlooked as an important source of HIV, leading to a significant gap in the literature about non-immune cell sources such as pvSMC as HIV reservoirs. Herein, we propose to determine the ability of pvSMC to support chronic HIV infection and their ability to spread HIV to bystander immune cells in the presence of ART. We also propose to investigate the cellular mechanisms for the resiliency of pvSMC to the cytopathic effects of HIV. This work should provide new insights into the potential of pulmonary vascular as SMC as reservoirs in the era of advanced ART. Knowing the characteristics of pvSMC as HIV reservoirs is imperative to further strategize for the effective eradication of a previously unappreciated HIV reservoir.
LOADING MOONBASE SCORE
Questions for TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Texas Tech University Health Scis CenterNot yet scored
Role of HIV gp120 and Nef in Transcriptome Dysregulation and Pulmonary Vascular Remodeling
Sharilyn Almodovar · $682K · 2023–2027
- NIH · Texas Tech University Health Scis Center61
Targeting mechanisms of glycosaminoglycan accumulation and neurobehavioral dysfunction to improve outcomes from traumatic brain injury
Aric Flint Logsdon · $193K · 2025–2028
- NIH · Texas Tech University Health Scis Center50
Endogenous Retroviruses and Alcohol Use Disorder
Dawei Li · $223K · 2025–2027